Literature DB >> 2257515

Radiation-induced malignant pleural mesothelioma.

A Kawashima1, H I Libshitz, J M Lukeman.   

Abstract

Malignant pleural mesothelioma is a rare and usually fatal disease. Its association with asbestosis is well recognized. The authors report a case of malignant pleural mesothelioma that developed 30 years after the patient underwent radiotherapy for breast cancer. This appears to be the first such case reported in the radiology literature.

Entities:  

Mesh：

Year:  1990        PMID： 2257515

Source DB:  PubMed          Journal:  Can Assoc Radiol J        ISSN： 0846-5371            Impact factor:   2.248


  6 in total

Review 1.  Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.

Authors:  Shoshana J Weiner; Siyamek Neragi-Miandoab
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-12       Impact factor: 4.553

2.  French cohort of the uranium processing workers: mortality pattern after 30-year follow-up.

Authors:  Irina Guseva Canu; Elisabeth Cardis; Camille Metz-Flamant; Sylvaine Caër-Lorho; Bernard Auriol; Pascal Wild; Dominique Laurier; Margot Tirmarche
Journal:  Int Arch Occup Environ Health       Date:  2009-08-23       Impact factor: 3.015

3.  Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.

Authors:  Shoshana J Weiner; Siyamek Neragi-Miandoab
Journal:  J Carcinog       Date:  2008-07-28

4.  Mesothelioma with non-pleural malignancy: a red herring or just an uncommon pairing?

Authors:  Andrew J Drain; Kourosh Saeb-Parsy; Amit K Shah; D Rassl; Andrew J Ritchie
Journal:  J Cardiothorac Surg       Date:  2006-11-01       Impact factor: 1.637

5.  Malignant Pleural Mesothelioma in Patients Who Previously Received Radiotherapy for Their First Malignant Tumor.

Authors:  Ikuo Sekine; Yoshiyuki Yamamoto; Toshio Suzuki; Hideo Suzuki
Journal:  Intern Med       Date:  2020-10-14       Impact factor: 1.271

6.  The Association between Malignant Pleural Mesothelioma and Thoracic Radiation Therapy for Hodgkin's Lymphoma: The First Case Report in Japan.

Authors:  Koki Nakashima; Yoshiki Demura; Masahiro Oi; Mio Tabata; Toshihiko Tada; Kohei Shiozaki; Masaya Akai; Tamotsu Ishizuka
Journal:  Intern Med       Date:  2020-10-14       Impact factor: 1.271
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.